Home › Compare › CTBO vs MCD

CTBO vs MCD: Dividend Comparison 2026

CTBO yields 198.02% · MCD yields 2.35%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CTBO wins by $112.62M in total portfolio value
10 years
CTBO
CTBO
● Live price
198.02%
Share price
$1.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$112.70M
Annual income
$56,534,499.65
Full CTBO calculator →
MCD
McDonald's Corporation
● Live price
2.35%
Share price
$308.53
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.5K
Annual income
$26,227.70
Full MCD calculator →

Portfolio growth — CTBO vs MCD

📍 CTBO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCTBOMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CTBO + MCD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CTBO pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTBO
Annual income on $10K today (after 15% tax)
$16,831.68/yr
After 10yr DRIP, annual income (after tax)
$48,054,324.70/yr
MCD
Annual income on $10K today (after 15% tax)
$200.01/yr
After 10yr DRIP, annual income (after tax)
$22,293.55/yr
At 15% tax rate, CTBO beats the other by $48,032,031.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTBO + MCD for your $10,000?

CTBO: 50%MCD: 50%
100% MCD50/50100% CTBO
Portfolio after 10yr
$56.39M
Annual income
$28,280,363.67/yr
Blended yield
50.15%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

CTBO
No analyst data
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+14.0% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTBO buys
0
MCD buys
0
No recent congressional trades found for CTBO or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCTBOMCD
Forward yield198.02% ✓2.35%
Annual dividend / share$2.00$7.26 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3% ✓
Portfolio after 10y$112.70M ✓$78.5K
Annual income after 10y$56,534,499.65 ✓$26,227.70
Total dividends collected$106.15M ✓$58.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: CTBO vs MCD ($10,000, DRIP)

YearCTBO PortfolioCTBO Income/yrMCD PortfolioMCD Income/yrGap
1← crossover$30,502$19,801.98$10,815$334.85+$19.7K → CTBO
2$89,086$56,448.56$11,826$491.71+$77.3K → CTBO
3$249,403$154,080.96$13,123$730.06+$236.3K → CTBO
4$670,003$403,142.26$14,853$1,100.07+$655.1K → CTBO
5$1,729,066$1,012,162.66$17,257$1,690.61+$1.71M → CTBO
6$4,291,289$2,441,188.37$20,752$2,667.01+$4.27M → CTBO
7$10,253,990$5,662,310.92$26,103$4,354.83+$10.23M → CTBO
8$23,616,660$12,644,890.45$34,794$7,437.78+$23.58M → CTBO
9$52,487,868$27,218,041.68$49,926$13,461.60+$52.44M → CTBO
10$112,696,518$56,534,499.65$78,550$26,227.70+$112.62M → CTBO

CTBO vs MCD: Complete Analysis 2026

CTBO — Stock

Cantabio Pharmaceuticals, Inc., a preclinical stage biotechnology company, focuses on the research, development, and commercialization of novel therapies for Parkinson's disease (PD), Alzheimer's disease (AD), and other related diseases. Its lead programs include CB101, a DJ-1 targeting small molecule pharmacological chaperone for use in the treatment of PD; CB201, a CNS penetrant engineered DJ-1 protein for use in the treatment of PD; CB301, a Tau protein targeting small molecule pharmacological chaperone for use in the treatment of AD; and CB401, an Aß targeting small molecule pharmacological chaperone for use in the treatment of AD. The company has a collaboration agreement with Luxembourg Institute of Health to research the therapeutic targeting of the DJ-1 - protein to treat immune associated diseases. The company was founded in 2009 and is based in Palo Alto, California.

Full CTBO Calculator →

MCD — Consumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this CTBO vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTBO vs SCHDCTBO vs JEPICTBO vs OCTBO vs KOCTBO vs MAINCTBO vs YUMCTBO vs QSRCTBO vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.